KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Other financing activities: 2013-2014

Historic Other financing activities for Xenon Pharmaceuticals (XENE) over the last 1 years, with Dec 2014 value amounting to $228,000.

  • Xenon Pharmaceuticals' Other financing activities rose 776.92% to $228,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2014, which is 44.03% down from last year.
  • As of Q4 2014, Xenon Pharmaceuticals' Other financing activities stood at $228,000, which was down 60.35% from $575,000 recorded in Q3 2014.
  • In the past 5 years, Xenon Pharmaceuticals' Other financing activities ranged from a high of $575,000 in Q3 2014 and a low of $26,000 during Q4 2013.
  • Over the past 2 years, Xenon Pharmaceuticals' median Other financing activities value was $332,000 (recorded in 2014), while the average stood at $311,800.
  • Data for Xenon Pharmaceuticals' Other financing activities shows a peak YoY skyrocketed of 776.92% (in 2014) over the last 5 years.
  • Over the past 2 years, Xenon Pharmaceuticals' Other financing activities (Quarterly) stood at $26,000 in 2013, then skyrocketed by 776.92% to $228,000 in 2014.
  • Its last three reported values are $228,000 in Q4 2014, $575,000 for Q3 2014, and $332,000 during Q2 2014.